What Is Maltase and What Does It Do in the Body?

Maltase is a digestive enzyme whose single job is to split the sugar maltose into two molecules of glucose, which your body can then absorb and use for energy. It sits on the inner lining of your small intestine and acts as one of the final steps in starch digestion, turning an intermediate sugar into fuel your cells actually recognize.¹ That sounds simple enough, but the biology behind maltase is more layered than the textbook one-liner suggests, and the enzyme’s absence or malfunction is linked to conditions ranging from chronic bloating to a serious muscle disease.

How Starch Becomes Glucose

When you eat bread, rice, pasta, or potatoes, you are eating starch, a long chain of glucose units linked together. Your body cannot absorb starch directly. It has to be dismantled into individual glucose molecules first, and that process happens in stages.

The first stage begins in your mouth. Salivary amylase starts chopping the long starch chains into shorter fragments, primarily maltose (a two-glucose unit) and slightly longer pieces called maltodextrins. This continues briefly in the stomach before pancreatic amylase takes over in the small intestine, producing even more maltose and short glucose chains.¹ But amylase can only break starch down so far. It cannot release free glucose on its own. That is where maltase comes in.

Maltase finishes the job. It cleaves the bond holding the two glucose molecules in maltose together, releasing free glucose that passes through the intestinal wall into your bloodstream. Without this final cleavage step, the maltose produced by amylase would sit in your gut unabsorbed, potentially causing gas, bloating, and diarrhea as bacteria ferment it instead.

Where Maltase Lives and How It Works

Maltase is not floating loose in your intestinal fluid. It is anchored to the surface of cells that line the inside of the small intestine, specifically to tiny finger-like projections called microvilli. Together, these microvilli form what is called the brush border, and maltase is classified as a brush-border enzyme. This placement is strategic: by sitting right on the surface where absorption happens, maltase can release glucose directly at the point of entry into the intestinal cell, making the whole process faster and more efficient.

The enzyme works by recognizing and grabbing the specific chemical bond that holds two glucose units together in maltose. It uses an active site, essentially a molecular pocket, to lock onto that bond and snap it apart. The activity is described technically as producing glucose from linear glucose polymers, and it is typically measured using maltose as the test substrate.²

Maltase-Glucoamylase and Its Partner Enzyme

In reality, maltase does not work alone. It is one active site on a larger protein called maltase-glucoamylase, or MGAM. This protein has two catalytic subunits, each capable of cleaving glucose from short starch fragments. The portion at one end of the protein handles maltose efficiently, while the portion at the other end can tackle larger maltodextrin fragments that amylase has only partially broken down, converting them directly to glucose.³ This dual capability means MGAM can handle both the small and medium-sized leftovers of amylase digestion.

MGAM does not do this work by itself, either. It teams up with a second brush-border enzyme called sucrase-isomaltase, or SI. These two proteins form a physical complex on the intestinal surface and together regulate the final steps of starch digestion. Research shows that SI actually assumes the larger role by volume, because it is expressed at higher levels in the intestinal lining, while MGAM acts in a supporting capacity.⁴ Both enzymes can break down maltose, but they handle other sugars differently. SI also digests sucrose (table sugar) and isomaltose, while MGAM does not touch sucrose at all.⁵

The two enzymes even share an evolutionary origin. Their genes have identical exon structures and about 59% amino acid sequence similarity, suggesting they arose from a gene duplication event long ago and then specialized into complementary roles.⁵ The MGAM gene itself sits on chromosome 7 and spans roughly 82,000 base pairs with 48 exons.

A Built-In Speed Brake on Digestion

One of the more interesting details about maltase-glucoamylase is that it comes with what researchers call a substrate “brake.” When slightly longer glucose chains, like three-, four-, or five-unit fragments, are present alongside maltose, they actually slow down the enzyme’s activity on the native, full-length protein.⁶ This braking effect lives specifically in the glucoamylase subunit. The maltase subunit, by contrast, is poorly inhibited by those same fragments and keeps working.

Why would an enzyme evolve to slow itself down? The likely answer has to do with controlling how fast glucose enters your bloodstream. If the entire enzyme complex worked at full speed all the time, you would get a sharper spike in blood sugar after eating starch. The built-in brake moderates that spike, parceling out glucose more gradually. This has caught the attention of researchers studying blood sugar management, because understanding this natural throttle could help design better treatments for conditions where post-meal glucose spikes are dangerous.

What Happens When Maltase Is Missing

Deficiency in maltase-glucoamylase is rare but real. One documented case involved an infant who was admitted to the hospital at two and a half months old with an inability to gain weight. The child was initially diagnosed with congenital lactase deficiency, but continued to struggle even on a formula containing glucose oligomers instead of lactose. Biopsies of the jejunum at four and twelve months showed normal tissue structure but decreased activity of maltase-glucoamylase, sucrase-isomaltase, and lactase, and breath testing confirmed that the child could not properly absorb starch in the upper intestine.⁷ Cases like this highlight that maltase deficiency can overlap with other disaccharidase deficiencies, making diagnosis tricky.

Symptoms of brush-border enzyme deficiencies in general mirror what you would expect when undigested sugars reach the large intestine: bloating, gas, abdominal cramps, and watery diarrhea. These overlap with irritable bowel syndrome and many other common gut complaints, so the condition often flies under the radar.

How Disaccharidase Deficiencies Are Diagnosed

The gold standard for diagnosing any disaccharidase deficiency, including maltase deficiency, is a biopsy of the small intestine taken during an endoscopy. At least two samples are usually collected: one to check the tissue architecture under a microscope and another to measure enzyme activity levels directly.⁸ The biopsy approach has a notable limitation, though. Enzyme deficiencies can be patchy along the intestinal lining, meaning a biopsy from one spot might miss the problem entirely.

Breath testing is the main non-invasive alternative. You drink a solution containing the sugar in question, and if your body cannot break it down, gut bacteria ferment it and produce hydrogen or methane that shows up in your breath. The drawback is that breath tests cannot always distinguish between different types of enzyme deficiency, and they can give false positives in people who have bacterial overgrowth in the small intestine.⁸ For a formal, definitive diagnosis, most gastroenterologists still rely on biopsy.⁹

Acid Maltase Deficiency Is a Different Condition Entirely

The phrase “maltase deficiency” sometimes gets confused with acid maltase deficiency, which is a completely separate disease with a different mechanism and a different set of consequences. Acid maltase deficiency is the older name for Pompe disease, a genetic disorder in which the lysosomal enzyme acid alpha-glucosidase is missing or nonfunctional.¹⁰ Lysosomes are the recycling compartments inside cells, responsible for breaking down waste material. When acid alpha-glucosidase is absent, glycogen accumulates inside these compartments, particularly in muscle tissue, leading to progressive muscle weakness.

The infantile form of Pompe disease is severe and, without treatment, usually fatal in the first year of life due to heart and respiratory muscle failure. Later-onset forms progress more slowly but still cause significant disability. The condition is caused by mutations in the GAA gene.¹¹ Enzyme replacement therapy, in which a manufactured version of the missing enzyme is infused intravenously, has transformed outcomes for many patients.

The confusion between intestinal maltase and acid maltase is understandable since both enzymes act on glucose linkages, but they operate in entirely different cellular locations, affect different organ systems, and arise from mutations in different genes. Research on human muscle tissue has confirmed that neutral maltase (the form active in digestion-range pH) and acid maltase (the lysosomal form) are distinct enzymatic activities. In patients with infantile acid maltase deficiency, the neutral maltase activity in muscle remains completely normal even while acid maltase activity is undetectable.¹²

Diabetes Drugs That Target Maltase Activity

If maltase helps turn starch into glucose, then slowing maltase down should reduce the blood sugar spike after a starchy meal. That is exactly the logic behind a class of diabetes medications called alpha-glucosidase inhibitors. The best known of these is acarbose, which has been prescribed for type 2 diabetes for decades.

Acarbose works by competitively inhibiting maltase-glucoamylase in the small intestine. It parks itself in the enzyme’s active site, preventing maltose and maltodextrins from being cleaved. Studies show that acarbose is a potent competitive inhibitor of both maltose and maltooligosaccharide hydrolysis by the enzyme.¹³ The result is that glucose is released more slowly from starch, flattening the post-meal blood sugar curve.

The trade-off is that undigested carbohydrates reaching the lower intestine can cause gas and bloating, which is why some patients stop taking acarbose. Researchers are investigating ways to improve this approach. One recent line of work explored combining acarbose with baicalein, a natural flavonoid found in the roots of a plant used in traditional Chinese medicine. In laboratory studies, baicalein bound to a different spot on the maltase-glucoamylase enzyme than acarbose does, enhancing the drug’s ability to shut down the enzyme’s activity in a synergistic way.¹⁴ Whether this combination translates into better clinical outcomes, or fewer side effects, remains to be seen.

Maltase, the Gut Microbiome, and Undigested Sugars

When maltase and its partner enzymes do their job well, very little undigested sugar reaches the colon. But when they do not, or when the system is overwhelmed, those sugars become food for the trillions of bacteria living in your gut. Recent research has drawn attention to a less appreciated aspect of this relationship: the small intestine has its own microbial community, and sugar metabolism by these small-intestinal microbes may not be benign.

Unlike the beneficial fermentation that colonic bacteria perform on complex fibers, sugar fermentation in the small intestine can produce toxic metabolites. These byproducts may serve as raw material for fatty acid synthesis, potentially contributing to negative metabolic effects for the host.¹⁵ This area of research is still young, but it raises the possibility that efficient maltase function does more than just ensure glucose absorption. It may also help prevent harmful microbial fermentation higher up in the digestive tract.

Maltase Outside the Human Body

Maltase is not just a human digestive enzyme. Versions of it exist across the biological world, from yeast to molds to bacteria, and several of these have been harnessed for industrial purposes. In food manufacturing, maltase is used to break down maltose into glucose during starch processing, which is a key step in producing glucose syrups. Those syrups are a major ingredient in soft drinks, baked goods, and many other processed foods. The enzyme also plays a role in brewing and distilling, where converting starch to fermentable sugars is essential for alcohol production.

The discovery of maltase-like activity actually predates the modern concept of enzymes altogether. In 1833, the French chemist Anselm Payen and his colleague Jean-François Persoz isolated a substance from malt extract that could convert starch into sugar. They named it diastase, from a Greek root meaning “to separate,” because they believed it separated sugar from starch. Diastase was later identified as alpha-amylase and became recognized as the first enzyme ever discovered in science, as well as the first maltase-like activity described.¹⁶ The terminology has evolved considerably since then, with “maltase” now referring specifically to the brush-border activity that cleaves maltose into glucose, but the lineage stretches all the way back to those early-nineteenth-century malt experiments.

Pancreatic and Supplemental Enzymes

People sometimes wonder whether you can take maltase as a supplement. Digestive enzyme supplements are widely available and contain varying combinations of enzymes that break down carbohydrates, proteins, and fats. Some formulations include amylase or glucoamylase, which overlap functionally with what maltase-glucoamylase does in the gut. These supplements are sometimes marketed for general digestive comfort, though their primary clinical use is in conditions where the body’s own enzyme production is genuinely impaired, such as pancreatic insufficiency in cystic fibrosis or chronic pancreatitis.

For the average person eating a normal diet, brush-border maltase activity is rarely the bottleneck in digestion. The enzyme is abundantly expressed along the length of the small intestine, and even if one patch of intestinal lining is underperforming, neighboring regions can compensate. True congenital maltase-glucoamylase deficiency is extraordinarily rare. The more common clinical scenario is secondary deficiency, where damage to the intestinal lining from celiac disease, Crohn’s disease, infections, or other causes temporarily reduces enzyme levels. In those cases, treating the underlying condition usually restores enzyme activity without the need for supplementation.

The mucosal enzyme system also shows some capacity to adapt to dietary changes. Animal studies and clinical observations suggest that the amount and type of carbohydrate in your diet can influence how much disaccharidase activity your intestinal lining produces. A diet consistently high in starch appears to upregulate these enzymes over time, while prolonged fasting or very-low-carbohydrate diets may temporarily reduce their activity, which could explain why some people experience digestive discomfort when they suddenly reintroduce starchy foods after a long period without them.